Company intelligence / Profile preview

Aclairo Pharmaceutical Development Group

Vienna, Virginia, United Statesaclairo.com ↗

Ownership: Private
Development stage: Other

Overview

Aclairo has supported hundreds of successful IND/NDA submissions for drugs and biologics. The company specializes in nonclinical pharmacology/toxicology/ADME/DMPK strategy and regulatory support. It does not have its own clinical pipeline but has contributed to the advancement of numerous client products through various development stages.

Therapeutic areas: Other
Modalities: Small moleculeBiologicDeviceDrug-device combination
Industry: Drug Discovery Services

Partnerships

EPL (parent company)Advyzom (regulatory strategy alliance)

Beyond the preview

Go deeper on Aclairo Pharmaceutical Development Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aclairo Pharmaceutical Development Group.

Explore the full profile